Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

UroGen Pharma (URGN) Other Non Operating Income (2017 - 2018)

Historic Other Non Operating Income for UroGen Pharma (URGN) over the last 2 years, with Q4 2018 value amounting to -$125000.0.

  • UroGen Pharma's Other Non Operating Income fell 99285.71% to -$125000.0 in Q4 2018 from the same period last year, while for Dec 2018 it was -$124000.0, marking a year-over-year decrease of 113333.33%. This contributed to the annual value of $6.9 million for FY2024, which is 2147.62% up from last year.
  • Latest data reveals that UroGen Pharma reported Other Non Operating Income of -$125000.0 as of Q4 2018, which was down 99285.71% from $1000.0 recorded in Q1 2018.
  • UroGen Pharma's Other Non Operating Income's 5-year high stood at $14000.0 during Q4 2017, with a 5-year trough of -$125000.0 in Q4 2018.